Details of the Drug Reposition

General Information of This Drug (ID: DMH8UF0)

• Drug Name: SY-1425 (DMH8UF0)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Myelodysplastic syndrome	DISYHNUI	2A37	Phase 1	[1]
Acute myeloid leukaemia	DIS0BM1I	2A60	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)